Mobile Airways Sentinel Network – MASK

MASK (Mobile Airways Sentinel Network), as part of the Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, involves more than 22 countries worldwide. It works closely with POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) and collaborates with professional and patient organisations in the field of allergies and respiratory diseases.

MASK offers real-world care pathways focused on the patient with rhinitis and/or multimorbidity asthma.

CIRFF actively participates in the ARIA in the PHARMACY working group, which aims to develop and study the use of digital devices for respiratory diseases in the community pharmacy setting.

Available results:

MASK

2019 ARIA Care pathways for allergen immunotherapy

ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study

The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study